Total Funding
63
49
Total FundingVenture - Series Unknown raised
Growth Score 63 in past quarter
-14 pts
Heat Score 49 in past quarter
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
62231
Cage Bio develops novel products for dermatology, inflammation, and immunology.
- Ravi Srinivasan: Co-Founder & ChairmanPast Role: i2o Therapeutics, Co-founder, President and CEO
- Nitin Joshi: Co-founder & Chief Executive Officer
About the Company
Cage Bio is a privately-held clinical-stage company exploiting its proprietary deep eutectic ionic liquid platform to develop novel products for dermatology, inflammation, and immunology. The company's mission is to develop highly effective topical products for localized treatment thereby minimizing side effects from systemic exposure.
Cage
Bio is headquartered in San Carlos, California.
